# Metopirone

NDC: 76336-455
Generic name: Metyrapone
Labeler / Manufacturer: HRA Pharma Rare Diseases
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, GELATIN COATED
Routes: ORAL
Marketing started: 19620125

FDA application: NDA012911

## Active ingredients

- METYRAPONE: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76336-455"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76336-455
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a27d0ef-83a7-4e1c-9430-46a3326ee8d8